Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $81,660,525    

Indirect Value

   $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634 Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 55 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2012-03-01 4 B $29.47 $450,543 I/I 15,288 7,967,364 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-01 4 B $29.47 $11,936 I/I 405 220,223 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-02 4 B $29.52 $323,899 I/I 10,972 1,461,872 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-02 4 B $29.52 $2,699,915 I/I 91,459 8,058,823 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-02 4 B $29.52 $71,410 I/I 2,419 222,642 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-10 4 B $29.86 $2,051,783 I/I 68,681 234,540 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-07 4 B $29.88 $17,420 I/I 583 227,324 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-07 4 B $29.88 $659,464 I/I 22,071 8,235,908 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-07 4 B $29.88 $70,097 I/I 2,346 1,482,815 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-09 4 B $29.90 $584,367 I/I 19,547 232,924 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-05 4 B $29.96 $558,037 I/I 18,597 1,480,469 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-05 4 B $29.96 $4,651,479 I/I 155,014 8,213,837 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-05 4 B $29.96 $122,998 I/I 4,099 226,741 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-11 4 B $30.22 $805,567 I/I 26,660 235,167 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-08 4 B $30.36 $15,668 I/I 516 227,840 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-08 4 B $30.36 $592,489 I/I 19,513 8,255,421 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-08 4 B $30.36 $65,647 I/I 2,162 1,484,977 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-14 4 B $31.53 $7,153,896 I/I 212,438 239,821 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-21 4 B $32.04 $4,826,973 I/I 150,000 246,683 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-22 4 B $32.94 $573,401 I/I 17,406 247,063 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-15 4 B $33.11 $4,772,474 I/I 140,000 242,888 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-16 4 B $34.46 $813,925 I/I 23,621 243,405 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-10-01 4 A $35.89 $10,336 D/D 288 288 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-07-13 4 B $41.20 $36,503,200 I/I 886,000 156,821 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2013-01-04 4 B $47.53 $40,862,492 I/I 859,720 176,920 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55  56      
  Page 55 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us